- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-09-0003064

About Desons Therapeutics Private Limited
Data last updated:
Desons Therapeutics Private Limited is a private limited company based in Dlf, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140HR2014PTC052104. Its GSTIN is 06AAFCD1064K2ZQ (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shakuntala and Prem Raj.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No. U – 10/7 Phase – III, DLF, Haryana, India – 122002.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.25 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹10.02 Lakh (net margin 3.1%) and EBITDA of ₹17.62 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Desons Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0003064). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website desons.in.
Company details
Recognitions & Rankings of Desons Therapeutics
Contact details
Desons Therapeutics Private Limited's registered office is in Dlf, Haryana. Its website is desons.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No. U – 10/7 Phase – III, DLF, Haryana, India – 122002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Desons Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Desons Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Desons Therapeutics Private Limited, buy the company report.
Financials of Desons Therapeutics Private Limited
FY 2024 filings availableDesons Therapeutics Private Limited reported revenue of ₹3.25 Cr (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 16% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Desons Therapeutics Private Limited, buy the company report.
Board of directors of Desons Therapeutics Private Limited
Desons Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shakuntala | Director | 14 Aug 2019 | 7 Years 2 Months | Current |
| Prem Raj | Director | 10 Mar 2014 | 12 Years 7 Months | Current |
| Kanchan Popli | Director | 10 Mar 2014 | 12 Years 7 Months | Current |
Auditor
Desons Therapeutics Private Limited is audited by GAUR DAVENDER & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAUR DAVENDER & CO. | FY 2023 | 023880N |
Shareholding
The shareholding of Desons Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Desons Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 May 2025 | 101099614 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Desons Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Desons Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Desons Therapeutics has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCD1064K2ZQ | Haryana | Active | 18 Jan 2024 |
To see the full GST registrations and return filing status of Desons Therapeutics Private Limited, buy the company report.
Recent activity
Desons Therapeutics Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Shakuntala was appointed as Director on 14 Aug 2019.
Frequently asked questions
Desons Therapeutics is an active private limited company based in Dlf, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 March 2014 (12+ years old) and is registered under CIN U74140HR2014PTC052104.
Desons Therapeutics has 3 current directors:
- Shakuntala - Director
- Prem Raj - Director
- Kanchan Popli - Director
The latest financial statements of Desons Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Desons Therapeutics is 06AAFCD1064K2ZQ, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Desons Therapeutics is U74140HR2014PTC052104. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Desons Therapeutics was incorporated on 10 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Shakuntala was appointed as Director on 14 Aug 2019. Kanchan Popli was appointed as Director on 10 Mar 2014. Prem Raj was appointed as Director on 10 Mar 2014.
Yes, Desons Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-09-0003064).
Desons Therapeutics can be reached through the website desons.in. Its registered office is in Dlf, Haryana, India.
The registered office of Desons Therapeutics is at H.No. U – 107 Phase – III, DLF, Haryana, India – 122002.

